Classen H G, Marquardt P, Späth M, Schumacher K A, Gräbling B
Arzneimittelforschung. 1978;28(5):807-11.
The peroral administration of magnesium and potassium compounds in effective doses (ED50) to rats yielded the following results: 1. Magnesium or potassium given as chlorides are significantly better absorbed than the corresponding aspartates. 2. In the presence of aspartate in higher concentrations the absorption of both magnesium and potassium is inhibited to a certain degree. 3. Increasing amounts of chloride cannot abolish the inhibitory effect of aspartate on potassium absorption, in contrast magnesium, which, in the presence of aspartate is better taken up when chloride is provided. 4. High concentrations of magnesium may perhaps impede the uptake of potassium to a small degree but not vice versa. 5. Magnesium losses from the body--induced by treatment with 9-alpha-fluorocortisol-acetate--can be effectively substituted by peroral administration of chloride-containing magnesium compounds over a reasonable time. The simultaneously occurring loss of potassium cannot be corrected correspondingly by potassium supplements.
给大鼠口服有效剂量(ED50)的镁和钾化合物,产生了以下结果:1. 以氯化物形式给予的镁或钾比相应的天冬氨酸盐吸收明显更好。2. 当存在较高浓度的天冬氨酸时,镁和钾的吸收均受到一定程度的抑制。3. 增加氯化物的量不能消除天冬氨酸对钾吸收的抑制作用,相反,对于镁,当提供氯化物时,在天冬氨酸存在的情况下其吸收更好。4. 高浓度的镁可能在一定程度上会阻碍钾的摄取,但反之则不然。5. 用9-α-氟皮质醇醋酸酯处理引起的体内镁流失,可通过在合理时间内口服含氯化物的镁化合物有效替代。同时发生的钾流失不能通过补充钾相应地得到纠正。